Stocks and Investing
Stocks and Investing
Fri, July 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sean Dodge Reiterated (CDMO) at Buy and Held Target at $8 on, Jul 3rd, 2024
Sean Dodge of RBC Capital, Reiterated "Avid Bioservices, Inc." (CDMO) at Buy and Held Target at $8 on, Jul 3rd, 2024.
Sean has made no other calls on CDMO in the last 4 months.
There is 1 other peer that has a rating on CDMO. Out of the 1 peers that are also analyzing CDMO, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $12 on, Monday, March 11th, 2024
Contributing Sources